.6 mg semaglutide The Indian government has approved #NovoNordisk's obesity drug, Wegovy, for the treatment of #fattyliver disease. Novo Nordisk said the Central Drugs Standard Control Organisation (CDSCO) approved #Wegovy's 2.4 injection for Peptide Sciences Semaglutide 6mg for

Rare but Serious Complications While most side effects of weight loss medications are manageable, some rare complications demand immediate medical attention

Many patients research Lipo B because they want more than a standard diet recommendation

Incretin-based therapies and lifestyle interventions: the evolving role of registered dietitian nutritionists in obesity care

To help preserve muscle and boost metabolism, we offer innovative NuForm treatments utilizing advanced muscle-stimulating technology that helps your body stay strong as you lose weight

This weakened response to GLP-1 can make it challenging to manage blood sugar levels in patients with diabetes and may require alternative treatment methods or adjustments in medication dosage. Medication interference People taking a GLP-1 drug with other medications may see less weight loss